FDA’s Approval of Genetically Engineered Fish will Head to Court.

As expected, the Center for Food Safety (among others) filed suit against the U.S. Food and Drug Administration for its approval of the AquaBounty Technologies genetically engineered Atlantic salmon for...

As expected, the Center for Food Safety (among others) filed suit against the U.S. Food and Drug Administration for its approval of the AquaBounty Technologies genetically engineered Atlantic salmon for sale as food within the U.S.

Among the many claims pled (the complaint runs 60+ pages) is that FDA’s NEPA routine (an environmental assessment and finding of no significant impact) failed to take a hard look at the potential environmental consequences of the approval, that it improperly segmentted the decision from other, similar actions, that it ignored potential cumulative impacts, that it lacked an adequate consideration of alternatives, and that it improperly relied upon mitigation measures to find no significant impact.  The plaintiffs filed in the Northern District of California.

The complaint can be found here.  Our earlier story is here.

I teach environmental, natural resources, and administrative law at Penn State Law. Before teaching I was an enforcement lawyer at U.S. EPA. Along the way I've done work for environmental nonprofits and written a fair bit about NEPA.
No Comment

Leave a Reply

RELATED BY